Gene therapy to cure leukemia at one-tenth global costs in the works
ImmunoACT, backed by Laurus Labs is testing their cancer product12-06-2022
12-06-2022
Laurus Labs Ltd - 540222 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find enclosed the newspaper advertisement regarding the 17th Annual General Meeting of the Company to be held through Video Conferencing (VC) and dispatch of Notice and Annual Report through electronic mode on June 06, 2022 as per the circulars issued by the Regulatory Authorities. The Advertisement appeared in the Business Standard (English Newspaper) and Prajasakthi (Telugu Newspaper) on June 09, 2022.09-06-2022
Laurus Labs Ltd - 540222 - Reg. 34 (1) Annual Report.
Pursuant to Regulation 34 of SEBI (LODR) Regulations, 2015, please find enclosed the Notice convening the 17th Annual General Meeting (AGM) of shareholders and the Annual Report for the financial year 2021-22 which will be circulated to the shareholders through electronic mode for the AGM to be held on Thursday, June 30, 2022 at 04.00 PM (IST) through video conference (VC).06-06-2022
Laurus Labs Ltd - 540222 - Notice Of The 17Th Annual General Meeting For FY 2021-22, To Be Held On June 30, 2022.
Please find enclosed the Notice convening the 17th Annual General Meeting (AGM) of shareholders for the financial year 2021-22 for the AGM to be held on Thursday, June 30, 2022 at 04.00 PM (IST) through video conference (VC).06-06-2022
Laurus Labs Ltd - 540222 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find enclosed the newspaper advertisement regarding the 17th Annual General Meeting of the Company to be held through Video Conferencing (VC) and proposed dispatch of Notice and Annual Report through electronic mode as per the circulars issued by the Regulatory Authorities. Thank You02-06-2022
Laurus Labs Ltd - 540222 - Certificate Under Regulation 40(9) Of SEBI (LODR) Regulations 2015
Please find enclosed the Certificate under Regulation 40(9) of SEBI (LODR) Regulations 2015, issued by the Practicing Company Secretary tor the year ended March 31, 202202-06-2022
Laurus Labs Ltd - 540222 - Disclosure Of Related Party Transactions For The Half Year Ended March 31, 2022
In Compliance with Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the details on Related Party Transactions for the half year ended March 31, 2022, prepared in accordance with the format specified by SEBI vide circular SEBI/HO/CFD/CMD1/CIR/P/2021/662 dated November 22, 2021. This is for your information and records. Thank You11-05-2022
Laurus Labs Ltd - 540222 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Please find enclosed the Annual secretarial compliance report required under Regulation 24A of the SEBI (LODR) Regulations, 2015, issued by the Practicing Company Secretary for the year ended March 31, 2022. This is for your information and records. Thank You11-05-2022
Laurus Labs Ltd - 540222 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Q4 FY22 Earnings call transcript for the call held on April 29, 202205-05-2022
Buy Laurus Labs; target of Rs 700: Motilal Oswal
Motilal Oswal is bullish on Laurus Labs recommended buy rating on the stock with a target price of Rs 700 in its research report dated April 29, 2022.03-05-2022